Company Filing History:
5 out of 81 
2 out of 44 Years Active: 2011-2025
Title: Koki Matsubara: Innovator in Pharmaceutical Chemistry
Introduction
Koki Matsubara is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 5 patents to his name, Matsubara's work has the potential to impact various medical treatments.
Latest Patents
Matsubara's latest patents focus on tetrahydroquinoline derivatives as P2X7 receptor antagonists. These inventions relate to tetrahydroquinoline derivatives or their pharmaceutically acceptable salts or prodrugs. The patents detail processes for their preparation, pharmaceutical compositions containing them, and their use in treating various disorders mediated via the P2X7 receptor. This innovative approach highlights the potential for new therapeutic options in managing diseases linked to this receptor.
Career Highlights
Throughout his career, Koki Matsubara has worked with notable companies in the pharmaceutical industry. He has been associated with Asahi Kasei Pharma Corporation and Raqualia Pharma Inc., where he has contributed to research and development efforts. His expertise in pharmaceutical chemistry has been instrumental in advancing the understanding and application of new drug compounds.
Collaborations
Matsubara has collaborated with esteemed colleagues in his field, including Hitoshi Kida and Shunsuke Kaneko. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their research.
Conclusion
Koki Matsubara is a distinguished inventor whose work in pharmaceutical chemistry continues to pave the way for new therapeutic advancements. His contributions, particularly in the area of P2X7 receptor antagonists, demonstrate his commitment to improving medical treatments. The significance of his patents and collaborations underscores the importance of innovation in the pharmaceutical industry.